• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病是烟雾病患者血运重建后发生缺血性卒中的独立危险因素:一项前瞻性队列研究。

Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study.

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.

China National Clinical Research Center for Neurological Diseases, Beijing, China.

出版信息

Lipids Health Dis. 2024 Mar 17;23(1):80. doi: 10.1186/s12944-024-02065-5.

DOI:10.1186/s12944-024-02065-5
PMID:38494486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10944598/
Abstract

BACKGROUND

The study aimed to investigate the association between nonalcoholic fatty liver disease (NAFLD) and ischemic stroke events after revascularization in patients with Moyamoya disease (MMD).

METHODS

This study prospectively enrolled 275 MMD patients from September 2020 to December 2021. Patients with alcoholism and other liver diseases were excluded. NAFLD was confirmed by CT imaging or abdominal ultrasonography. Stroke events and modified Rankin Scale (mRS) scores at the latest follow-up were compared between the two groups.

RESULTS

A total of 275 patients were enrolled in the study, among which 65 were diagnosed with NAFLD. Univariate logistic regression analysis showed that NAFLD (P = 0.029) was related to stroke events. Multivariate logistic regression analysis showed that NAFLD is a predictor of postoperative stroke in MMD patients (OR = 27.145, 95% CI = 2.031-362.81, P = 0.013). Kaplan-Meier analysis showed that compared with MMD patients with NAFLD, patients in the control group had a longer stroke-free time (P = 0.004). Univariate Cox analysis showed that NAFLD (P = 0.016) was associated with ischemic stroke during follow-up in patients with MMD. Multivariate Cox analysis showed that NAFLD was an independent risk factor for stroke in patients with MMD (HR = 10.815, 95% CI = 1.259-92.881, P = 0.030). Furthermore, fewer patients in the NAFLD group had good neurologic status (mRS score ≤ 2) than the control group (P = 0.005).

CONCLUSION

NAFLD was an independent risk factor for stroke in patients with MMD after revascularization and worse neurological function outcomes.

摘要

背景

本研究旨在探讨非酒精性脂肪性肝病(NAFLD)与烟雾病(MMD)患者血管再通后缺血性卒中事件的关系。

方法

本研究前瞻性纳入 2020 年 9 月至 2021 年 12 月期间的 275 例 MMD 患者。排除酒精性肝病和其他肝病患者。通过 CT 成像或腹部超声检查确认 NAFLD。比较两组患者的卒中事件和随访时的改良 Rankin 量表(mRS)评分。

结果

本研究共纳入 275 例患者,其中 65 例诊断为 NAFLD。单因素 logistic 回归分析显示,NAFLD(P=0.029)与卒中事件相关。多因素 logistic 回归分析显示,NAFLD 是 MMD 患者术后卒中的预测因素(OR=27.145,95%CI=2.031-362.81,P=0.013)。Kaplan-Meier 分析显示,与 MMD 合并 NAFLD 患者相比,对照组患者的无卒中时间更长(P=0.004)。单因素 Cox 分析显示,NAFLD(P=0.016)与 MMD 患者随访期间的缺血性卒中相关。多因素 Cox 分析显示,NAFLD 是 MMD 患者卒中的独立危险因素(HR=10.815,95%CI=1.259-92.881,P=0.030)。此外,NAFLD 组的患者神经功能状态良好(mRS 评分≤2)的比例低于对照组(P=0.005)。

结论

NAFLD 是 MMD 患者血管再通后卒中的独立危险因素,且神经功能预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae4/10944598/41f3b750e95e/12944_2024_2065_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae4/10944598/c102146c808d/12944_2024_2065_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae4/10944598/41f3b750e95e/12944_2024_2065_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae4/10944598/c102146c808d/12944_2024_2065_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae4/10944598/41f3b750e95e/12944_2024_2065_Figa_HTML.jpg

相似文献

1
Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study.非酒精性脂肪性肝病是烟雾病患者血运重建后发生缺血性卒中的独立危险因素:一项前瞻性队列研究。
Lipids Health Dis. 2024 Mar 17;23(1):80. doi: 10.1186/s12944-024-02065-5.
2
dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.dl-3-n-丁基邻苯二甲酸酯治疗烟雾病颅内外联合血管重建术后神经功能缺损的疗效:倾向评分匹配分析。
J Neurosurg. 2019 Feb 15;132(2):421-433. doi: 10.3171/2018.10.JNS182152. Print 2020 Feb 1.
3
Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.中国成人烟雾病的临床特征、外科治疗和长期预后。
Cerebrovasc Dis. 2012;34(4):305-13. doi: 10.1159/000343225. Epub 2012 Nov 8.
4
Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.成人缺血性烟雾病直接旁路与间接旁路治疗:倾向评分匹配分析。
J Neurosurg. 2018 Jun;128(6):1785-1791. doi: 10.3171/2017.2.JNS162405. Epub 2017 Aug 11.
5
Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.烟雾病的临床特征与长期预后:中国单中心528例病例经验
J Neurosurg. 2015 Feb;122(2):392-9. doi: 10.3171/2014.10.JNS132369. Epub 2014 Nov 28.
6
Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.成人症状性烟雾病的旁路手术与药物治疗的比较。
J Neurosurg. 2017 Sep;127(3):492-502. doi: 10.3171/2016.8.JNS152875. Epub 2016 Nov 11.
7
Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.通过直接血运重建对成年起病的烟雾病伴缺血患者进行卒中预防。
J Neurosurg. 2016 Jun;124(6):1788-93. doi: 10.3171/2015.6.JNS151105. Epub 2015 Dec 4.
8
Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.小儿烟雾病的脑-硬脑膜-动脉血管融合术:单中心100例长期随访
J Neurosurg Pediatr. 2018 Aug;22(2):173-180. doi: 10.3171/2018.2.PEDS17591. Epub 2018 Jun 1.
9
Clinical Implications of the "Brush Sign" in Susceptibility-Weighted Imaging for Moyamoya Disease."Brush Sign"在磁共振磁敏感加权成像对烟雾病诊断中的临床意义
Cerebrovasc Dis. 2021;50(2):147-155. doi: 10.1159/000511936. Epub 2021 Feb 8.
10
Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type.按发病类型分类的成人烟雾病旁路手术的结果。
JAMA Netw Open. 2024 Jun 3;7(6):e2415102. doi: 10.1001/jamanetworkopen.2024.15102.

本文引用的文献

1
Clinical value of the systemic immune-inflammation index in moyamoya disease.烟雾病中全身免疫炎症指数的临床价值
Front Neurol. 2023 Apr 20;14:1123951. doi: 10.3389/fneur.2023.1123951. eCollection 2023.
2
The Role of the Soluble Interleukin-6 Receptor in the Progression of Nonalcoholic Fatty Liver Disease.可溶性白细胞介素-6 受体在非酒精性脂肪性肝病进展中的作用。
Bull Exp Biol Med. 2023 Mar;174(5):628-633. doi: 10.1007/s10517-023-05759-5. Epub 2023 Apr 13.
3
Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis.
脂代谢、体重指数与普通人群非酒精性脂肪性肝病风险的关系:基于中介分析的证据。
J Transl Med. 2023 Mar 13;21(1):192. doi: 10.1186/s12967-023-04047-0.
4
Moyamoya disease emerging as an immune-related angiopathy.烟雾病表现为免疫相关性血管病。
Trends Mol Med. 2022 Nov;28(11):939-950. doi: 10.1016/j.molmed.2022.08.009. Epub 2022 Sep 14.
5
Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease.低高密度脂蛋白血症是成人烟雾病血管重建术后长期随访期间复发性中风的一个预测指标。
Front Neurol. 2022 Jul 26;13:891622. doi: 10.3389/fneur.2022.891622. eCollection 2022.
6
TG/HDL-C ratio as a predictor of stroke in the population with healthy BMI: The Jichi Medical School Cohort Study.载脂蛋白 TG/高密度脂蛋白胆固醇比值预测健康体重人群脑卒中发病风险:日本自治医科大学队列研究。
Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1872-1879. doi: 10.1016/j.numecd.2022.05.002. Epub 2022 May 16.
7
Moyamoya disease: diagnosis and interventions.烟雾病:诊断与干预。
Lancet Neurol. 2022 Aug;21(8):747-758. doi: 10.1016/S1474-4422(22)00165-X. Epub 2022 May 20.
8
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease.非酒精性脂肪性肝病 (NAFLD) 与心血管疾病之间关系的病理生理机制和临床证据。
Rev Cardiovasc Med. 2021 Sep 24;22(3):755-768. doi: 10.31083/j.rcm2203082.
9
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.动脉粥样硬化性心血管疾病及其以外的血管内皮功能障碍:从机制到药物治疗。
Pharmacol Rev. 2021 Jul;73(3):924-967. doi: 10.1124/pharmrev.120.000096.
10
Interplay between inflammation and thrombosis in cardiovascular pathology.心血管病理学中的炎症与血栓形成的相互作用。
Nat Rev Cardiol. 2021 Sep;18(9):666-682. doi: 10.1038/s41569-021-00552-1. Epub 2021 May 6.